Episode Details

After a woman finishes her breast cancer treatment and is ringing the bell, a quiet concern often remains: the possibility of recurrence. Even after successful cancer treatment, early-stage breast cancers can return in 30% of cases. 

This video aims to provide essential patient education for any cancer patient facing this reality, emphasizing the need for continued vigilance in oncology.

🎯 What You’ll Learn in This Episode

• Why breast cancer can return after treatment
• What “watch and wait” typically means
• The difference between early-stage and metastatic disease
• Why tumor biology varies between patients
• The role of immune function in cancer care
• What deeper testing may include
• Why monitoring matters beyond imaging
• How to think about long-term survivorship

📍 Envita Medical Centers – Scottsdale, AZ
🌐 Learn more: www.envita.com
📞 Speak with a care coordinator: 866-830-4576

“Finishing treatment isn’t the end — it’s the beginning of long-term strategy.”

Disclaimer
This podcast is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always consult your licensed healthcare provider before making any medical decisions. Individual results will vary, and Envita Medical Centers does not guarantee outcomes. Some treatments discussed may not be FDA-approved or available in all locations. Testimonials are shared with patient consent and may not reflect typical results. Do not delay or disregard professional medical care based on the podcast's content. Certain treatments may be available only at Envita’s international clinic in Hermosillo, Mexico. No specific outcomes are promised or implied.
________________________________________
Outcomes Disclaimer
The results referenced from Envita's Precision Cancer Care: 35-Fold Improvement in Response Rates are from a retrospective analysis of 199 late-stage cancer patients treated at Envita Medical Centers between 2021 and 2023, as published in the Journal of Cancer Therapy. These outcomes are not guaranteed and will vary based on individual factors such as cancer type, stage, genetics, immunity and prior treatments. Any comparisons to standard care or clinical trials are based on published data and internal analysis, not head-to-head studies. Individual results will vary.

You can read the full peer-reviewed study at: 

https://www.scirp.org/journal/paperinformation?paperid=132493